A Population-Based Study of Antenatal Corticosteroid Prophylaxis for Preterm Birth

Trends in receipt of single and repeat courses of antenatal corticosteroid administration among preterm and term births: A retrospective cohort study

“…Previous studies have reported variable ACS administration rates among live births below 35 weeks gestation of between 35–93% . While not always clear as to whether such administration relates to a partial or complete single course of ACS as evaluated in this study, studies reporting optimal administration have uniformly demonstrated low rates of 25–50% of livebirths, More recently, interest has grown in determining what defines optimal ACS administration.…”

“34 Weeks” of Gestation—Lost in Translation

“…4 We believe that it is, not only to optimize outcomes but also to emphasize that we should say what we mean. In the realm of the hypertensive disorders, there are other examples of terms that mean different things to different people.…”

Glycemic management after antenatal corticosteroid therapy

“…In fact, women with gestational diabetes were more likely (odds ratio 1.21; 95% confidence interval 1.05-1.40) to receive ACS in a study conducted in British Columbia, Canada. [4]…”